Search

everythinglearnresearchcommunity

for

Search:↓

Improving mangiferin's solubility and delivery can enhance its health benefits.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Type I interferons play a key role in the development of various skin diseases.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

FOXO1 is important for wound healing, but its dysfunction in diabetes can slow the healing process.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.